Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Clinical trial NCT01313884 · TERMINATED
Trial details
- NCT number
- NCT01313884
- Sponsor
- Stanford University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.